I'd love to see a summary of each of the 12 cases (without identity), but doubt we will get that any time soon.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-1939
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.018(1.16%) |
Mkt cap ! $1.712B |
Open | High | Low | Value | Volume |
$1.50 | $1.54 | $1.48 | $4.226M | 2.811M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 56729 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.54 | 14401 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 51903 | 1.525 |
15 | 42407 | 1.520 |
12 | 39083 | 1.515 |
6 | 30160 | 1.510 |
9 | 121546 | 1.505 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 87072 | 15 |
1.535 | 29980 | 7 |
1.540 | 160303 | 10 |
1.545 | 111237 | 5 |
1.550 | 189483 | 24 |
Last trade - 14.39pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online